Schonfeld Strategic Advisors’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Schonfeld Strategic Advisors’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-15,500	Closed	-$49K	–	3406
2022 Q2	$49K	Sell	15,500 -10,600	-41%	-$41.3K	﹤0.01%	2226
2022 Q1	$112K	Buy	26,100 +10,400	+66%	+$45.3K	﹤0.01%	2204
2021 Q4	$73K	Hold	15,700	–	–	﹤0.01%	1921
2021 Q3	$62K	Sell	15,700 -800	-5%	-$3.17K	﹤0.01%	1986
2021 Q2	$71K	Buy	16,500 +300	+2%	+$1.28K	﹤0.01%	1859
2021 Q1	$68K	Buy	+16,200	New	+$89.3K	﹤0.01%	1704
2018 Q1	–	Sell	-32,703	Closed	-$1.05M	–	1096
2017 Q4	$1.05M	Buy	+32,703	New	+$1.07M	0.09%	300
2017 Q3	–	Sell	-7,255	Closed	-$216K	–	889
2017 Q2	$216K	Buy	7,255 +73	+1%	+$2.09K	0.02%	542
2017 Q1	$214K	Buy	+7,182	New	+$183K	0.02%	537

Schonfeld Strategic Advisors's LJPC Position: Q3 2022 in Review

Schonfeld Strategic Advisors sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2022, closing a stake of 15,500 shares — an estimated $49K sold.

Schonfeld Strategic Advisors first reported a position in LJPC in Q1 2017 and held it in 9 quarters. The position peaked at $1.05M in Q4 2017. 0 funds tracked by Wall St. Rank hold LJPC as of Q3 2022.

Schonfeld Strategic Advisors reported no remaining La Jolla Pharmaceutical Company position as of Q3 2022 after selling out during the quarter.
Schonfeld Strategic Advisors sold 15,500 La Jolla Pharmaceutical Company shares in Q3 2022, an estimated $49K.
Schonfeld Strategic Advisors first reported a position in La Jolla Pharmaceutical Company in Q1 2017 and held it in 9 quarters.
Schonfeld Strategic Advisors's La Jolla Pharmaceutical Company position peaked at $1.05M in Q4 2017.
0 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.